Topics:

Diatech files IND for infection agent

Diatech files IND for infection agent

Peptide-based imaging agent developer Diatech of Londonderry, NH, has filed an investigational new drug (IND) application with the Food and Drug Administration for a new radiopharmaceutical that detects infections of unknown origin. The agent, Tc-99m P483H, is a technetium-99m-labeled synthetic peptide designed to home in on infection sites where white blood cells are elevated as the body fights infection.

Disclosures

 
Loading comments...
Please Wait 20 seconds or click here to close